Examining the effectiveness of amygdala and insula retraining (AIR) program on psychological indicators and sleep patterns in fibromyalgia patients

Examining the effectiveness of amygdala and insula retraining (AIR) program on psychological indicators and sleep patterns in fibromyalgia patients.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210119050079N2

Enrollment

Registered

2023-02-21

Start date

2023-02-25

Completion date

Unknown

Last updated

2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia. Fibromyalgia

Interventions

Intervention 1: Intervention group: In the Amygdala and Insula recovery intervention, the hypothesis is that changing emotion and cognition is more effective when the body moves. This psychotherapy ap

It will include stretching movements, hypothetical line movements, cross-arm movements, arm rotations, neck rotations, cross-leg movements, sit-ups, 2) static aerobic exercise

Includes climbers walking, Palank, Palank with knee touch, and ski movement. 3) Dynamic aerobic exercise

It will include jogging at 70% of your maximum heart rate. 4) cooling down

It will include stretching, cross-linking, sitting, lying down and cradle movement. Exercises are performed with behavioral techniques and with the guidance of sports instructors and in a modified man

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age between 18 and 70 year Having an FM diagnostic in accordance with the American College of Rheumatology (ACR) 1990 criteria and provided by a rheumatologist working for the Iranian National Health Service Being able to read and understand Persian

Exclusion criteria

Exclusion criteria: Presence of severe Axis I psychiatric/somatic disorder, autoimmune disease, or the use of corticosteroid medication Participation in a concurrent RCT. As long as the patients agreed not to change their medication dosage during the RCT period, they were not asked to discontinue their regular pattern of medication which was considered part of their usual care. Medication was maintained stable 3 months prior the study and throughout the study.

Design outcomes

Primary

Measure	Time frame
Symptoms of Depression. Timepoint: Before intervention- 8 weeks later- 4 weeks later. Method of measurement: Beck Questionnaire.;Symptoms of Anxiety. Timepoint: Before intervention- 8 weeks later- 4 weeks later. Method of measurement: Beck Questionnaire.;Perceived Stress. Timepoint: Before intervention- 8 weeks later- 4 weeks later. Method of measurement: Cohen Questionnaire.;Emotion Regulation. Timepoint: Before intervention- 8 weeks later- 4 weeks later. Method of measurement: Emotion Regulation Problems Questionnaire.;Sleep Quality. Timepoint: Before intervention- 8 weeks later- 4 weeks later. Method of measurement: Pittsburgh Questionnaire.;Sleep Pattern. Timepoint: Before intervention- 8 weeks later- 4 weeks later. Method of measurement: Insomnia Severity Scale and Sleep tables.	—

Measure

Time frame

Symptoms of Depression. Timepoint: Before intervention- 8 weeks later- 4 weeks later. Method of measurement: Beck Questionnaire.;Symptoms of Anxiety. Timepoint: Before intervention- 8 weeks later- 4 weeks later. Method of measurement: Beck Questionnaire.;Perceived Stress. Timepoint: Before intervention- 8 weeks later- 4 weeks later. Method of measurement: Cohen Questionnaire.;Emotion Regulation. Timepoint: Before intervention- 8 weeks later- 4 weeks later. Method of measurement: Emotion Regulation Problems Questionnaire.;Sleep Quality. Timepoint: Before intervention- 8 weeks later- 4 weeks later. Method of measurement: Pittsburgh Questionnaire.;Sleep Pattern. Timepoint: Before intervention- 8 weeks later- 4 weeks later. Method of measurement: Insomnia Severity Scale and Sleep tables.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHabibolah Khazaie

Kermanshah University of Medical Sciences

hakhazaie@gmail.com+98 83 1824 9353

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026